文献速递青光眼小儿眼科与斜弱视

儿童难治性青光眼AADI植入:颞上象限与鼻下象限手术结局比较

Surgical Outcomes of Superotemporal Versus Inferonasal Placement of Aurolab Aqueous Drainage Implant in Refractory Pediatric Glaucoma.
PubMed 文献 · Am J Ophthalmol · 2020-12-10

该回顾性对比干预病例系列研究纳入144例(144眼)≤18岁难治性青光眼患儿,比较Aurolab房水引流植入物(AADI)植入于颞上(ST)象限(96眼)与鼻下(IN)象限(48眼)的2年结局。结果显示IN组眼压更高、用药更多,管暴露并发症显著更多,ST象限植入的眼压相关结局更好且更安全。

要点

  • AADI植入颞上象限者2年眼压及用药数优于鼻下象限。
  • 鼻下象限组管暴露发生率显著高于颞上象限组(12% vs 0%)。
  • 除非颞上位置不可行,儿童应避免鼻下象限植入AADI。

核心结论

  • 儿童难治性青光眼AADI植入颞上象限的眼压相关结局优于鼻下象限,且是更安全的手术选择。

研究设计与样本

  • 回顾性对比干预病例系列,纳入≤18岁接受AADI植入并完成至少2年随访的患儿共144例(144眼)。

主要发现

  • 2年随访时鼻下组眼压显著高于颞上组(17.5 ± 7.4 mm Hg vs 13.7 ± 6.2 mm Hg,P = .005)。
  • 2年随访时鼻下组用药数显著多于颞上组(1.5 ± 1.0 vs 0.8 ± 0.9,P = .001)。
  • 2年累积成功率鼻下组为50.7%(95%CI 35.4%-63.9%),颞上组为65.6%(95%CI 56.5%-75.7%),P = .15。
  • 鼻下组并发症更常见,管暴露显著更多(12% vs 0%,P = .05)。

关键数值与推荐

  • 2年累积成功定义为:术后3个月后连续2次随访眼压≤21 mm Hg或较基线降低≥20%,或连续2次随访眼压≤5 mm Hg,或因青光眼或并发症再手术,或丧失光感。

临床怎么用

  • 在儿童难治性青光眼中优先选择颞上象限植入AADI,除非颞上位置不可行。
  • 鼻下象限植入时需警惕管暴露等并发症风险增高。

局限性

  • 回顾性设计,象限选择基于瘢痕范围和结膜活动度,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to describe the outcomes of the Aurolab aqueous drainage implant (AADI) placed in the superotemporal (ST) versus the inferonasal (IN) quadrant in pediatric eyes with refractory glaucoma. DESIGN: Retrospective comparative interventional case series. METHODS: This was a retrospective study of patients ≤18 years of age who underwent AADI implantation and completed a minimum of 2-year follow-up. The choice of the quadrant depended upon the amount of scarring and conjunctival mobility. Cumulative success at 2 years was defined as intraocular pressure (IOP) ≤21 mm Hg or reduced by ≥20% below baseline on 2 consecutive follow-up visits after 3 months, IOP ≤5 mm Hg on 2 consecutive follow-up visits after 3 months, reoperation for glaucoma or a complication, or loss of light perception vision. RESULTS: A total of 144 patients (144 eyes) underwent AADI placement, including 48 eyes (33%) in the IN and 96 eyes (67%) in the ST quadrants. The IOP was significantly higher in the IN group (17.5 ± 7.4 mm Hg vs 13.7 ± 6.2 mm Hg, P = .005) with a greater number of medications (1.5 ± 1.0 vs 0.8 ± 0.9, P = .001) after 2 years of follow-up. Cumulative success rates at 2 years were 50.7% (95% confidence interval 35.4%-63.9%) in the IN group and 65.6% (95% confidence interval 56.5%-75.7%) in the ST group (P = .15). Complications occurred more frequently in the IN group, with significantly more tube exposure (12% vs 0%, P = .05). CONCLUSIONS: Placement of the AADI in the ST quadrant has better IOP-related outcomes and is a safer surgical option in pediatric eyes compared with the IN quadrant. It may be prudent to avoid AADI in the IN quadrant in children unless the ST location is not a viable option.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Puthuran GV, Wijesinghe HK, Gedde SJ, et al. Surgical Outcomes of Superotemporal Versus Inferonasal Placement of Aurolab Aqueous Drainage Implant in Refractory Pediatric Glaucoma. Am J Ophthalmol. 2020. PMID: 33309809. doi:10.1016/j.ajo.2020.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。